Ratnakar Securities Pvt. Ltd.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE13267.6077.3 (+0.59 %)

PREV CLOSE ( ) 13190.30

OPEN PRICE ( ) 13100.00

BID PRICE (QTY) 13254.60 (1)

OFFER PRICE (QTY) 13280.70 (2)

VOLUME 501

TODAY'S LOW / HIGH ( )13100.00 13474.95

52 WK LOW / HIGH ( )6378 18089.55

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984

Management Info

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

11Jun Neuland Laboratories informs about ana
Neuland Laboratories has informed that the Companyâ€™s management will b..

09Jun Clarification sought from Neuland Lab
The Exchange has sought clarification from Neuland Laboratories Ltd on J..

16May Neuland Laboratories informs about ne
Pursuant to Regulation 47 of the Securities and Exchange Board of India..

16May Neuland Laboratories approves dividend
Neuland Laboratories has informed that the Board of Directors at their m..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	277.34	2594.26
Gross Profit	389.82	3453.74
Operating Profit	582.18	3428.08
Net Sales	3283.6	14768.37

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Eris Lifesciences (BSE) 1884.35 (5.02%)	M.Cap ( in Cr)24437.89
Pfizer (BSE) 5944.50 (1.04%)	M.Cap ( in Cr)26913.85
Onesource Specialty (BSE) 2072.80 (2.39%)	M.Cap ( in Cr)23171.93
RPG Life Sciences (BSE) 2385.75 (1.98%)	M.Cap ( in Cr)3869.30
FDC (BSE) 518.00 (8.79%)	M.Cap ( in Cr)7752.20

Shareholding Pattern

	MUTUAL FUNDS/UTI	7.43%
	NON-INSTITUTION	33.84%
	PROMOTERS	32.68%
	FI/BANKS/INSURANCE	0.96%
	GOVERNMENT	0.4%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
LIC MF Healthcare F...	3.29
JM Small Cap Fund-Reg(G)	2.78
Bajaj Finserv Healt...	2.76
HSBC Small Cap Fund...	2.34
ITI Pharma & Health...	2.28
PGIM India Healthca...	1.96

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

NEULAND LABORATORIES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES